Solventum Corp reported 3.64B in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
Abbott USD 50.83B 1.76B Jun/2025
Align Technology USD 3.79B 57.74M Mar/2025
Baxter International USD 7.05B 90M Mar/2025
Becton, Dickinson and Co. USD 25.47B 231M Jun/2025
Cencora USD 2.21B 1.98B Jun/2025
Dexcom USD 2.57B 306.5M Jun/2025
Insulet USD 1.46B 132.2M Jun/2025
Solventum Corp 3.64B 383M Jun/2025
West Pharmaceutical Services USD 2.93B 246M Jun/2025
Zimmer Biomet Holdings USD 12.53B 130.5M Jun/2025